LNTH

#1285
Lantheus Holdings, Inc
83.9400 USD
+1.45%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
83.9400
83.9400
Intervallo Annuale
50.1550
84.3800
Variazione giornaliera
+1.45%
Variazione Mensile
+4.93%
Variazione di 6 mesi
+49.73%
Variazione Annuale
+49.73%
Chiusura Precedente
82.7400
Apertura
83.9400
Bid
Ask
Minimo
83.9400
High
83.9400
Volume
90
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 5.423 B
  • Employee 1 193
  • Founded N/A
  • CEO N/A
  • Website www.lantheus.com
  • Headquarter Delaware, United States
  • FIGI BBG006Q52RD0
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
19.52
Rapporto prezzo/fatturato
2.95

Lantheus Holdings Inc

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

Notizie